Metraipolis › archive › dc_caaedbe23f8d

OnabotulinumToxinA Reduces Pharmacological Burden in Chronic Migraine Patients: A Two-Center Prospective Cohort Study — Europe PMC PMID:41893566

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41893566
DOI: 10.3390/toxins18030143
License (as archived): solo-consultazione
Archived: 2026-11-04T09:48:08.956Z
SHA-256 of the archived text: 1210ec8631ed457f5e463c2c2d2c42bae1bf85ea11a472ea34e1fefa7c8e007c
Stable URL of this page: https://metraipolis.com/documento/dc_caaedbe23f8d

How to cite

OnabotulinumToxinA Reduces Pharmacological Burden in Chronic Migraine Patients: A Two-Center Prospective Cohort Study — Europe PMC PMID:41893566 — Europe PMC (en), https://europepmc.org/article/MED/41893566 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_caaedbe23f8d (Metraipolis archive dc_caaedbe23f8d, sha256 1210ec8631ed457f5e463c2c2d2c42bae1bf85ea11a472ea34e1fefa7c8e007c)

BibTeX

@misc{dccaaedbe23f8d,
  title = {OnabotulinumToxinA Reduces Pharmacological Burden in Chronic Migraine Patients: A Two-Center Prospective Cohort Study — Europe PMC PMID:41893566},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41893566},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_caaedbe23f8d; sha256 1210ec8631ed457f5e463c2c2d2c42bae1bf85ea11a472ea34e1fefa7c8e007c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41893566. Agents can read the archived copy with the MCP tool read_document.